藥明康德新藥開發(fā)有限公司于2000年12月成立，是全球領(lǐng)先的制藥、生物技術(shù)以及醫(yī)療器械研發(fā)開放式能力和技術(shù)平臺公司，在中美兩國均有運營實體。作為一家以研究為首任，以客戶為中心的公司，藥明康德向全球制藥公司、生物技術(shù)公司以及醫(yī)療器械公司提供一系列全方位的實驗室研發(fā)、研究生產(chǎn)服務(wù)，服務(wù)范圍貫穿從藥物發(fā)現(xiàn)到推向市場的全過程。藥明康德的服務(wù)旨在通過高性價比、高效率的研發(fā)服務(wù)幫助全球客戶縮短藥物及醫(yī)療器械研發(fā)周期、降低研發(fā)成本。ｕ００２６lt；brｕ００２６gt；established in december 2000, wuxi apptec （nyse: wx） is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in china and the united states. as an innovation-driven and customer-focused company, wuxi apptec provides a broad and integrated portfolio of services throughout the drug rｕ００２６d process. our services are designed to help our worldwide customers shorten the discovery and development time and lower the cost of drug and medical device rｕ００２６d through cost-effective and efficient solutionsｕ００２６lt；brｕ００２６gt；ｕ００２６lt；brｕ００２６gt；